Abstract
There is the limited treatment for hepatocellular carcinoma (HCC) which is one of the most common cancers. Preventive control has been strongly emphasized for HCC. Researchers have begun to consider complementary and alternative medicines (CAM) as a means to treat and reduce the risk of gastrointestinal diseases. The probiotic bacteria Lactobacillus reuteri (L. reuteri) is shown to exert beneficial effects on the host by decreasing side effects of illnesses such as diarrhea, lactose intolerance, colorectal and liver cancer. Antioxidants are bioactive nutrients found in fruits and vegetables that can prevent or slow oxidative damage. Antioxidants act as “free radical scavengers“ to prevent free radical damage. Both probiotic and antioxidants are shown to have a beneficial inhibitor response in promoting apoptosis. To date, there is no research study on HCC with the probiotic L. Reuteri. Therefore, we hypothesize that probiotic Lactobacillus reuteri (L. reuteri) supplemented with selected antioxidants will enhance cell death in hepatocellular carcinoma. In this human‐derived HEPG2 cell culture study L. reuteri with our selected antioxidants demonstrates the effectiveness in altering the cancerous morphology and demonstrates a synergistic chemopreventive effect.Grant Funding Source: NSF Opt‐ED, Biology
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.